top of page
5Y0A4518.jpg

Dr. Ektor Panayi, MD PD PhD is considered to be one of the

BEST PLASTIC SURGEONS IN GREECE

Dr. Ektor Panayi, MD PD PhD (Greek: Ektoras Hadjipanayi)  carried out his medical education in some of Europe’s most prestigious institutions. After obtaining a medical degree (MD) at the famous University of Cambridge (UK), he completed a PhD in Biomedical Engineering at the University College London (UCL, UK).  He then carried out his training in General Surgery at Addenbrooke's NHS Cambridge University Hospital, followed by training in Plastic & Reconstructive Surgery at Bogenhausen Hospital in Munich, under world-renowned plastic & reconstructive surgeon  Prof. Milomir Ninkovic.

Dr. Panayi currently holds the position of Associate Professor of Plastic & Reconstructive Surgery at the Technical University of Munich (TUM), one of Germany's most acclaimed Universities, having led the plastic surgery research department for 5 years. He is also the Director of the Department of Plastic Surgery at Lefkos Stavros Hospital, one of Athen's State of the Art  Private Hospitals.

He has over 20 years experience in cosmetic surgery, focusing on facial rejuvenation, and body contouring procedures. His specialty includes Facelift, Rhinoplasty, Breast Surgery and Body Liposculpture.  He is one of the most highly distinguished plastic surgeons in Greece, and has pioneered / contributed to several breakthroughs in plastic and reconstructive surgery. Dr Panayi also has an outstanding academic career, achieving world-renowned status for his research work and innovations in the field of regenerative medicine and wound healing. He has authored multiple high-impact international scientific publications, obtained 6 international patents on various innovations in the filed of biomedical engineering, while his work has been cited in more than 10 books on regenerative medicine and plastic surgery. For his ground-breaking contribution, he has received many international awards, such as the German Prize for innovation in Biotechnology 2013 and the Science4Life Award 2016.

Awards 3_edited.jpg
LOGOS NEWS.jpg
LOGOS NEWS.jpg
CERTIFICATES

EDUCATION CERTIFICATES

SCIENTIFIC BOOKS

MEDIA&PRESS

MEDIA PUBLICATIONS

PRESS RELEASES

SELECTED SCIENTIFIC PUBLICATIONS

1.Comparison of the Effect of Different Conditioning Media on the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes: Towards Engineering Next-Generation Autologous Growth Factor Cocktails.

Moog P, Hughes J, Jiang J, Röper L, Dornseifer U, Schilling AF, Machens HG, Hadjipanayi E.

Int J Mol Sci. 2023 Mar 13;24(6):5485. doi: 10.3390/ijms24065485.

PMID: 36982558 Free PMC article.

2. Hypoxia Preconditioned Serum (HPS)-Hydrogel Can Accelerate Dermal Wound Healing in Mice-An In Vivo Pilot Study.

Jiang J, Kraneburg U, Dornseifer U, Schilling AF, Hadjipanayi E, Machens HG, Moog P.

Biomedicines. 2022 Jan 14;10(1):176. doi: 10.3390/biomedicines10010176.

PMID: 35052855 Free PMC article.

3.Effect of Hypoxia Preconditioned Secretomes on Lymphangiogenic and Angiogenic Sprouting: An in Vitro Analysis.

Moog P, Schams R, Schneidinger A, Schilling AF, Machens HG, Hadjipanayi E, Dornseifer U.

Biomedicines. 2020 Sep 20;8(9):365. doi: 10.3390/biomedicines8090365.

PMID: 32962277 Free PMC article.

4.Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes.

Moog P, Jensch M, Hughes J, Salgin B, Dornseifer U, Machens HG, Schilling AF, Hadjipanayi E.

Biomedicines. 2020 Aug 11;8(8):283. doi: 10.3390/biomedicines8080283.

PMID: 32796694 Free PMC article.

5.Comparative Evaluation of the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes and Platelet-Rich Plasma: An In Vitro Analysis.

Moog P, Kirchhoff K, Bekeran S, Bauer AT, von Isenburg S, Dornseifer U, Machens HG, Schilling AF, Hadjipanayi E.

Biomedicines. 2020 Jan 16;8(1):16. doi: 10.3390/biomedicines8010016.

PMID: 31963131 Free PMC article.

6.In Vitro Characterization of Hypoxia Preconditioned Serum (HPS)-Fibrin Hydrogels: Basis for an Injectable Biomimetic Tissue Regeneration Therapy.

Hadjipanayi E, Moog P, Bekeran S, Kirchhoff K, Berezhnoi A, Aguirre J, Bauer AT, Kükrek H, Schmauss D, Hopfner U, Isenburg S, Ntziachristos V, Ninkovic M, Machens HG, Schilling AF, Dornseifer U.

J Funct Biomater. 2019 May 13;10(2):22. doi: 10.3390/jfb10020022.

PMID: 31086048 Free PMC article.

7.The MEEK technique: 10-year experience at a tertiary burn centre.

Almodumeegh A, Heidekrueger PI, Ninkovic M, Rubenbauer J, Hadjipanayi E, Broer PN.

Int Wound J. 2017 Aug;14(4):601-605. doi: 10.1111/iwj.12650. Epub 2016 Aug 4.

PMID: 27489175 Free PMC article.

8.The Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical Control.

Hadjipanayi E, Kuhn PH, Moog P, Bauer AT, Kuekrek H, Mirzoyan L, Hummel A, Kirchhoff K, Salgin B, Isenburg S, Dornseifer U, Ninkovic M, Machens HG, Schilling AF.

PLoS One. 2015 Aug 28;10(8):e0135618. doi: 10.1371/journal.pone.0135618. eCollection 2015.

PMID: 26317771 Free PMC article.

9.Regeneration through autologous hypoxia preconditioned plasma.
Hadjipanayi E, Schilling AF.
Organogenesis. 2014 Apr-Jun;10(2):164-9. doi: 10.4161/org.29208. Epub 2014 May 15.
PMID: 24831225 Free PMC article.


10.Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration.
Hadjipanayi E, Schilling AF.
Organogenesis. 2013 Oct 1;9(4):261-72. doi: 10.4161/org.25970. Epub 2013 Aug 8.
PMID: 23974216 Free PMC article. Review.


11.Cell-free carrier system for localized delivery of peripheral blood cell-derived engineered factor signaling: towards development of a one-step device for autologous angiogenic therapy.
Hadjipanayi E, Bauer AT, Moog P, Salgin B, Kuekrek H, Fersch B, Hopfner U, Meissner T, Schlüter A, Ninkovic M, Machens HG, Schilling AF.
J Control Release. 2013 Jul 10;169(1-2):91-102. doi: 10.1016/j.jconrel.2013.04.008. Epub 2013 Apr 19.
PMID: 23603614


12.Injectable system for spatio-temporally controlled delivery of hypoxia-induced angiogenic signalling.
Hadjipanayi E, Cheema U, Hopfner U, Bauer A, Machens HG, Schilling AF.
J Control Release. 2012 Aug 10;161(3):852-60. doi: 10.1016/j.jconrel.2012.04.048. Epub 2012 May 22.
PMID: 22634070

 

13.First implantable device for hypoxia-mediated angiogenic induction.
Hadjipanayi E, Cheema U, Mudera V, Deng D, Liu W, Brown RA.
J Control Release. 2011 Aug 10;153(3):217-24. doi: 10.1016/j.jconrel.2011.03.029. Epub 2011 Mar 31.
PMID: 21458514


14.Controlling physiological angiogenesis by hypoxia-induced signaling.
Hadjipanayi E, Brown RA, Mudera V, Deng D, Liu W, Cheema U.
J Control Release. 2010 Sep 15;146(3):309-17. doi: 10.1016/j.jconrel.2010.05.037. Epub 2010 Jun 9.
PMID: 20538024


15.Identification of key factors in deep O2 cell perfusion for vascular tissue engineering.
Cheema U, Hadjipanayi E, Tammi N, Alp B, Mudera V, Brown RA.
Int J Artif Organs. 2009 Jun;32(6):318-28. doi: 10.1177/039139880903200602.
PMID: 19670183

CLINICAL COLLABORATIONS

Dr. Panayi has worked in many countries around the world, including Germany, UK, China, Sweden and France, and has performed, in association with such international teams, breakthrough surgical procedures in the field of plastic & reconstructive surgery (e.g. urinary bladder reconstruction, pectus excavatum 3D repair, burn surgery with MEEK technique). Every year, he treats multiple patients from around the world, including prestigious and VIP individuals. He has also built  numerous collaborations with multiple private hospitals in Greece and Cyprus and currently holds the position of Director of the Department of Plastic and Reconstructive Surgery at Lefkos Stavros Hospital in central Athens, one of the most modern state of the Art Private Clinics in Greece. For more information please visit www.lefkosstavros.gr

lefkos-stavros-logo.jpg
bottom of page